Online first
Short communication
Published online: 2024-10-08

open access

Page views 188
Article views/downloads 107
Get Citation

Connect on Social Media

Connect on Social Media

Clinical pathways of patients with heart failure with preserved ejection fraction hospitalized for acute heart failure: Insights from the National Multi-Centre HF-POL Registry

Jacek T Niedziela1, Mariusz Gąsior1, Monika Budnik2, Marek Gierlotka3, Jarosław D Kasprzak4, Bartosz Krakowiak5, Paweł Krzesiński6, Jadwiga Nessler7, Agnieszka Pawlak8, Anna Tomaszuk-Kazberuk9, Krystian Wita10, Małgorzata Lelonek11, on behalf of HF-POL investigators

Abstract

Not available

Article available in PDF format

View PDF Download PDF file

References

  1. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021; 42: 3599–3726.
  2. Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2022; 145: e895–e1032.
  3. Vergaro G, Ghionzoli N, Innocenti L, et al. Noncardiac versus cardiac mortality in heart failure with preserved, midrange, and reduced ejection fraction. J Am Heart Assoc. 2019; 8(20): e013441.
  4. Bozkurt B, Coats AJ, Tsutsui H, et al. Universal definition and classification of heart failure: A report of the Heart Failure Society of America, Heart Failure Association of the European Society of Cardiology, Japanese Heart Failure Society and Writing Committee of the universal definition of heart failure. J Card Fail. 2021; 27(4): 387–413.
  5. Major K, Sawościan M, Budnik M, et al. Baseline characteristics of Polish patients with heart failure with ejection fraction >40%: Results of HF-POL, the first study of the Heart Failure Association. Pol Heart J. 2024; 82(4): 427–430.
  6. Lelonek M, Gąsior M, Grabowski M. The HF-POL study — the first real-life multicenter study of Polish patients with heart failure and left ventricular ejection fraction >40%: Study rationale and design. Kardiol Pol. 2022; 80(11): 1145–1147.
  7. Lelonek M, Pawlak A, Straburzyńska-Migaj E, et al. Identification and therapy for patients with heart failure with preserved ejection fraction: An expert opinion of the Heart Failure Association of the Polish Cardiac Society. Pol Heart J. 2024; 82(2): 247–254.